METHOD OF TREATMENT OF PSORIASIS

• Main Authors: GOL'TSEVA TAMARA ALEKSANDROVNA, GROMOV KONSTANTIN GEORGIEVICH, URBANSKIJ ALEKSANDR SERGEEVICH, CHASOVNIKOV KONSTANTIN VIKTOROVICH, MEDVEDEVA NATAL'JA LEONIDOVNA, CHEKUSHIN RAMIL' KHUSANOVICH
• Format: Patent
• Language: English; Russian
• Published: 10.07.2007
• Subjects: DIAGNOSIS; ELECTROTHERAPY; HUMAN NECESSITIES; HYGIENE; IDENTIFICATION; MAGNETOTHERAPY; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; RADIATION THERAPY; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SURGERY; ULTRASOUND THERAPY

FIELD: medicine; dermatology. ^ SUBSTANCE: photo-chemotherapy course is taken four times a week during four weeks. Prolactin and thryrotrophic hormone is found in blood. Parlodel is prescribed at specific factors in parallel with photo-chemotherapy. In case factors of prolactin grow higher than 720 mME/l and thryrotrophic hormone gets higher than 4,2 mcME/ml, parlodel is introduced before meals in amount of 1,25 mg twice a day in mornings and evenings during 30 days. Then it is introduced during 2 months in amount of 0,625 mg mornings and evenings. Then parlodel is introduced during 3 months in amount of 0,625 mg twice a day in the evening and in the morning. In 6 months levels of prolactin and thryrotrophic hormone are checked again. If prolactin factors excess 65-720 mME/l and thryrotrophic hormone factors excess 0,4-4,2 mcME/l, introduction of prolactin is canceled. If prolactin factor is higher than 720 mME/l and thryrotrophic hormone factor is higher than 4,2 mcME/l, course is repeated. ^ EFFECT: improved efficiency of treatment; prolonged remission periods; reduced side effects. ^ 3 att